Triphin 500 mg/vial (IV Injection)
500 mg vial: ৳ 120.37
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Ziska pharmaceuticals ltd |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
- Broad-spectrum parenteral cephalosporin antibiotic
- Bactericidal activity against a wide range of Gram-positive and Gram-negative organisms
- Long plasma elimination half-life of about 6 to 9 hours
- High stability in the presence of beta lactamases
- Not metabolized in the body
- Excretion in urine and bile
- Highly protein bound (95%)
Dosage
- Adult dose: 1 to 2 gm by intravenous or intramuscular administration once a day
- Maximum adult dose: 4 gm/day
- Uncomplicated gonococcal infections: 250 mg IM as a single dose
- Surgical prophylaxis: 1 g IV as a single dose 30 to 120 minutes before surgery
- Infants and Children dose: 50 to 75 mg/kg intravenous or intramuscular administration once a day
- Maximum pediatric dose: 2 gm/day
- Duration of therapy: 4 to 14 days
Administration
- Preparation of Solutions for Intramuscular / Intravenous Injections
- Multiple options for dissolving Ceftriaxone for Intramuscular or Intravenous Injection
- Recommended administration over 2-4 minutes by Intramuscular or Intravenous injection
Interaction
- No drug interactions reported
Contraindications
- History of hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea and vomiting, stomatitis and glossitis
- Cutaneous reactions including rash, pruritus, urticaria, edema and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia and dizziness
- Local phlebitis occurs rarely following intravenous administration
Pregnancy & Lactation
- Safety in human pregnancy not established
- Use in pregnancy only if absolutely indicated
- Low concentrations of Ceftriaxone excreted in human milk
- Caution when administered to a lactating mother
Precautions & Warnings
- Anaphylactic shock possibility
- Shadows suggesting sludge in the gallbladder in rare cases
- Regular blood picture checks during prolonged treatment
Use in Special Populations
- Not to be given to premature and newborn neonates
Overdose Effects
- No specific antidote. Treatment should be symptomatic
Therapeutic Class
- Third generation Cephalosporins
Storage Conditions
- Store in a cool, dry place (below 30°C), away from light & moisture